Yamaguchi Yoshitaka, Wada Manabu, Tanji Haruko, Kurokawa Katsuro, Kawanami Toru, Tanji Kazuyo, Yoneda Makoto, Kato Takeo
Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Japan.
Intern Med. 2013;52(11):1249-53. doi: 10.2169/internalmedicine.52.9373.
A 67-year-old man receiving antithrombotic therapy developed rapidly progressive amnesia. T2-weighted images of brain MRI revealed hyperintense lesions in the bilateral thalami accompanied by microbleeds. Antithyroglobulin antibodies and autoantibodies against the N-terminal of α-enolase (NAE) were identified in the patient's serum; therefore, Hashimoto's encephalopathy (HE) was suspected. Although the patient's radiological findings improved following steroid therapy, his symptoms did not improve, possibly due to increased thalamic microbleeds. Because anti-NAE antibodies are possibly associated with vasculitis, HE accompanied by anti-NAE antibodies may be exacerbated by microbleeds in patients receiving antithrombotic therapy.
一名正在接受抗血栓治疗的67岁男性出现了快速进展的失忆症。脑部MRI的T2加权图像显示双侧丘脑有高信号病变,并伴有微出血。在患者血清中检测到抗甲状腺球蛋白抗体和针对α-烯醇化酶N端(NAE)的自身抗体;因此,怀疑为桥本脑病(HE)。尽管患者在接受类固醇治疗后影像学表现有所改善,但其症状并未改善,可能是由于丘脑微出血增加所致。由于抗NAE抗体可能与血管炎有关,接受抗血栓治疗的患者中,伴有抗NAE抗体的HE可能会因微出血而加重。